Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Noronex Ltd. ( (AU:NRX) ) has issued an update.
Noronex Ltd has lodged an application with the ASX for quotation of 7,069,921 ordinary fully paid shares under code NRX, with an issue date of 2 April 2026. The securities form part of a previously announced transaction and, once quoted, will expand the company’s listed share base, potentially enhancing liquidity and broadening its investor participation.
The move reflects Noronex’s ongoing use of equity markets to support its corporate and funding strategies, aligning with prior Appendix 3B disclosures to the market. For existing shareholders, the additional quoted securities may lead to dilution but could also underpin future capital formation and operational progress if the underlying transaction advances the company’s projects.
The most recent analyst rating on (AU:NRX) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Noronex Ltd. stock, see the AU:NRX Stock Forecast page.
More about Noronex Ltd.
Noronex Ltd is an ASX-listed company operating under the ticker NRX. While the announcement provides limited operational detail, Noronex typically participates in the resources sector, with its ordinary fully paid shares traded on the Australian Securities Exchange, giving investors exposure to its exploration and development activities.
Average Trading Volume: 1,091,651
Technical Sentiment Signal: Sell
Current Market Cap: A$6.29M
Find detailed analytics on NRX stock on TipRanks’ Stock Analysis page.